INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 98 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,651,000 | +498.4% | 573,735 | +1539.2% | 0.00% | +100.0% |
| Q2 2017 | $443,000 | -6.7% | 35,000 | -22.6% | 0.00% | 0.0% |
| Q1 2017 | $475,000 | -78.6% | 45,200 | -81.3% | 0.00% | -75.0% |
| Q4 2016 | $2,222,000 | -28.7% | 241,500 | -8.7% | 0.00% | -33.3% |
| Q3 2016 | $3,118,000 | +4.9% | 264,500 | +15.2% | 0.01% | 0.0% |
| Q2 2016 | $2,971,000 | +43.6% | 229,600 | +215.8% | 0.01% | +20.0% |
| Q3 2015 | $2,069,000 | -59.1% | 72,700 | -48.3% | 0.01% | -58.3% |
| Q2 2015 | $5,054,000 | +447.0% | 140,700 | +784.9% | 0.01% | +500.0% |
| Q1 2015 | $924,000 | -83.7% | 15,900 | -88.4% | 0.00% | -85.7% |
| Q1 2014 | $5,679,000 | +2.9% | 137,080 | -13.1% | 0.01% | +7.7% |
| Q3 2013 | $5,518,000 | – | 157,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 788,175 | $10,199,000 | 4.68% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,987,313 | $116,296,000 | 2.40% |
| Antipodean Advisors LLC | 305,294 | $3,951,000 | 2.39% |
| Freshford Capital Management, LLC | 475,984 | $6,159,000 | 1.81% |
| Folger Hill Asset Management LP | 1,597,945 | $20,677,000 | 1.61% |
| JW Asset Management, LLC | 150,638 | $1,949,000 | 1.55% |
| 12 West Capital Management LP | 623,791 | $8,072,000 | 1.30% |
| Orbimed Advisors | 4,688,240 | $60,666,000 | 0.63% |
| CYPRESS FUNDS LLC | 135,584 | $1,754,000 | 0.41% |
| Rock Springs Capital Management LP | 365,500 | $4,730,000 | 0.35% |